France – Social work and related services – Mise en place et gestion d'un dispositif d'agents de médiation

France – Radiotherapy devices and supplies – FOURNITURE D’EQUIPEMENTS ET LOGICIELS DE RADIOTHERAPIE ET PRESTATIONS ASSOCIEES

France – Laboratory reagents – 051_2026_AO_Lecteurs glycémie_cétonémie

France – Functional support – SALLE HYPOXIQUE DE REEDUCATION

France – Domestic animal nurseries – CONTROLE_PEUPLEMENT_ANIMALIER

France – Dental consumables – Fourniture de matériels et consommables pour l’enseignement et les travaux pratiques de l’Ecole de Médecine Dentaire de Marseille

France – Imaging equipment for medical, dental and veterinary use – Fourniture, livraison et mise en service de scanners intraoraux sans fil pour les membres des Hôpitaux du Hainaut-Cambrésis

Expected Outcome: This action will establish a strategic European initiative to develop scalable, modular, and interoperable photonic quantum computing platforms. Proposals for this topic are expected to address and provide credible solutions to at least two major technical roadblocks currently limiting the advancement of photonic quantum computing such as: The lack of deterministic, high-efficiency photonic entanglement and loss-tolerant architectures suitable for fault-tolerant scaling The absence of a standardised, integrated control stack combining photonic hardware, firmware, and system software with reliable benchmarking across platforms Project results are expected to contribute to the following expected outcomes: By 2028, demonstration of a photonic NISQ processor with ≥100 photonic qubits, integrating deterministic single-photon sources, low-loss waveguides, on-chip detectors, and a firmware stack (scheduler, controller, compiler), validated via hardware-agnostic benchmarks and hybrid photonic-HPC applications demonstrating classical-quantum crossover By 2030, delivery of a full-stack, high-connectivity photonic quantum computer, with modular scalability, integrated…

Expected Impact: The action under this topic is expected to achieve the following impacts: Accelerate EU access to more cost-effective interventions in an increasingly ageing population by identifying personalised treatment approaches for elderly-onset immune diseases. Decrease disease risk later in life by defining specific prevention strategies based on ageing biomarkers and risk factors. Halt age-associated disease exacerbation by the identification of predictive and digital biomarkers that can stratify patients for early intervention. Improve quality of life for healthy individuals and patients by preventing further health decline, avoiding escalating care costs, and properly stratifying individuals earlier in the diagnostic pathway. Accelerate adoption of innovative diagnostic, preventative, and therapeutic strategies, strengthening the EU’s position as a healthcare innovator. Evaluate digital biomarker as potential regulatory endpoints in the ultimate goal to develop medicines for ‘healthy ageing’. Integrate fragmented research efforts by bringing together health industry sectors and stakeholders to develop clinical and multi-omics data integration capabilities. Enable new…

Expected Outcome: Project should contribute to all of the following expected outcomes: Research funders, policymakers and research communities in the social sciences and humanities (SSH) are provided with a multi-annual R&I programme on social transformations and resilience, responding to megatrends like climate change and biodiversity loss, digitalisation, demographic changes and unexpected shocks. Research investments on social protection and essential services, future of work, education and skills, and a fair transition to climate neutrality are increased. Stakeholders, including social partners and civil society, and policymakers are provided with evidence-based knowledge, tools and innovative solutions, which contribute to new policies and strategies for strengthening resilience, fairness, inclusiveness and social cohesion at European, national and regional level. Scope: Europe is undergoing critical social transformations driven by macro drivers of change, such as climate change, biodiversity loss, digitalisation and demographic change, which have been accelerated by events, such as the COVID-19 pandemic and Russia’s war of aggression against Ukraine. These transformations…

Expected Outcome: Proposals are expected to contribute to all following points: The projects must fulfil the performance targets, at the cell and system level, corresponding to the specific targeted application, to be specified in the proposal. Appropriate KPI must be defined for the energy density (volumetric and gravimetric), Power density and C-rate, number of cycles and cost defined under operational conditions. Boost EU competitiveness in next-generation battery technologies for mobility applications. Develop pilot manufacturing capability for next generation lithium-based batteries. Strengthen the EU battery value chain, including new manufacturing equipment, automation, and scalable production processes. Advance the understanding of next-generation battery interfaces at an industrial scale, ensuring manufacturability, durability, and cost-effectiveness. In the case of aviation, the battery requirements should be compatible at minimum with EASA CS.23 (level 4), CS.27 and preferably with CS.25 categories. Scope: This topic will support the scaling-up of next generation (i.e., beyond generation 3) lithium-based batteries (e.g., semi and all-solid state, generation5) from cell…